NKGN OTC
NKGen Biotech, Inc.
1W: -8.3%
1M: +10.0%
3M: -81.7%
YTD: -78.0%
1Y: -90.0%
$0.01
-0.00 (-8.33%)
Weekly Expected Move ±255.5%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$21M
+4.9% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$21M
+5.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$2M
+968.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | -$23M | -$27M | -$83M | -$44M |
| Depreciation & Amort. | $1M | $2M | $1M | $1M |
| Stock-Based Comp. | $93K | $69K | $4M | $4M |
| Change in Working Capital | $932K | $30K | $2M | $0 |
| Other Non-Cash Items | $1M | $2M | $60M | $18M |
| Operating Cash Flow | -$20M | -$23M | -$22M | -$21M |
| — Investing Activities — | ||||
| Capital Expenditures | -$459K | -$163K | -$48K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | -$172M | $0 | $0 | $0 |
| Investment Sales | $0 | $569K | $0 | $0 |
| Other Investing | $172M | -$569K | $0 | -$13K |
| Investing Cash Flow | -$459K | -$163K | -$48K | -$13K |
| — Financing Activities — | ||||
| Net Debt Issuance | $20M | $22M | $26M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $161K | -$6M | $21M |
| Financing Cash Flow | $20M | $22M | $22M | $21M |
| Net Change in Cash | $152K | -$234K | $159K | $2M |
| Cash End of Period | $351K | $117K | $276K | $2M |
| Free Cash Flow | -$20M | -$23M | -$22M | -$21M |